Logo image of NTB.CA

NEW TYMBAL RESOURCES LTD (NTB.CA) Stock Fundamental Analysis

Canada - TSX-V:NTB - CA6490171007 - Common Stock

0.02 CAD
0 (0%)
Last: 8/26/2025, 7:00:00 PM
Fundamental Rating

1

NTB gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 807 industry peers in the Metals & Mining industry. NTB has a bad profitability rating. Also its financial health evaluation is rather negative. NTB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

NTB had negative earnings in the past year.
In the past year NTB has reported a negative cash flow from operations.
NTB.CA Yearly Net Income VS EBIT VS OCF VS FCFNTB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 -200K -400K -600K

1.2 Ratios

NTB has a worse Return On Assets (-269.38%) than 83.96% of its industry peers.
Industry RankSector Rank
ROA -269.38%
ROE N/A
ROIC N/A
ROA(3y)-199.49%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NTB.CA Yearly ROA, ROE, ROICNTB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 0 -50 -100 -150 -200 -250

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NTB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NTB.CA Yearly Profit, Operating, Gross MarginsNTB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, NTB has about the same amount of shares outstanding.
The debt/assets ratio for NTB is higher compared to a year ago.
NTB.CA Yearly Shares OutstandingNTB.CA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 5M 10M 15M
NTB.CA Yearly Total Debt VS Total AssetsNTB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 1M 2M 3M 4M 5M

2.2 Solvency

NTB has an Altman-Z score of -64.63. This is a bad value and indicates that NTB is not financially healthy and even has some risk of bankruptcy.
NTB has a worse Altman-Z score (-64.63) than 81.84% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -64.63
ROIC/WACCN/A
WACCN/A
NTB.CA Yearly LT Debt VS Equity VS FCFNTB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 2M -2M 4M -4M

2.3 Liquidity

NTB has a Current Ratio of 1.21. This is a normal value and indicates that NTB is financially healthy and should not expect problems in meeting its short term obligations.
NTB's Current ratio of 1.21 is in line compared to the rest of the industry. NTB outperforms 45.27% of its industry peers.
NTB has a Quick Ratio of 1.21. This is a normal value and indicates that NTB is financially healthy and should not expect problems in meeting its short term obligations.
NTB has a Quick ratio (1.21) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.21
NTB.CA Yearly Current Assets VS Current LiabilitesNTB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 1M 2M 3M 4M

0

3. Growth

3.1 Past

NTB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -31.56%.
EPS 1Y (TTM)-31.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

NTB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NTB.CA Price Earnings VS Forward Price EarningsNTB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NTB.CA Per share dataNTB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15 -0.2 -0.25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NTB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NEW TYMBAL RESOURCES LTD

TSX-V:NTB (8/26/2025, 7:00:00 PM)

0.02

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.1%
Ins Owner ChangeN/A
Market Cap358.80K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.3
TBVpS-0.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -269.38%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-199.49%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.21
Altman-Z -64.63
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.13%
OCF growth 3YN/A
OCF growth 5YN/A